Stephen Wilton
Fortuna: 75 911 $ al 30/06/2026
Fortuna: 75 911 $ al 30/06/2026
Stephen Wilton is currently an Independent Director at BioSyent, Inc. since 2014.
Formerly, Mr. Wilton was Executive Director-Business Development at AstraZeneca Pharmaceuticals LP from 1993 to 2010 and Vice President-Pharmacy Affairs at The Canadian Association of Chain Drug Stores from 2011 to 2012.
Education includes an undergraduate degree from the University of Toronto and an MBA from The Schulich School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOSYENT INC. 0,07 % | 24/03/2026 | 7.435 ( 0,07 % ) | 75 911 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOSYENT INC. | Director/Miembro de la Junta | 16/01/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
The Canadian Association of Chain Drug Stores | Corporate Officer/Principal | 01/01/2012 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
BioSyent, Inc.
BioSyent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
The Canadian Association of Chain Drug Stores | |
The Schulich School of Business
The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.